These genetic alterations (e.g., mutations in CTNNB1 and WTX) or loss of heterozygosity on specific chromosomes (1p, 1q, 11p15, and 16q) have also been linked to nephroblastoma development, highlighting their usefulness in prognostic assessments [128,129]. This evidence concerns the gene AMER1 and Wilms tumor.